Department store chain Dillard’s sued Wells Fargo on Thursday (May 22), alleging that the bank breached a co-branded credit card relationship that has since ended.Dillard’s alleges that this breach cost it tens of millions of dollars, Reuters reported Thursday, citing a “heavily redacted complaint” filed in Manhattan federal court.Neither Dillard’s nor Wells Fargo immediately replied to PYMNTS’ request for comment.According to the Reuters report, Dillard’s alleges that Wells Fargo became an “unwilling and i ...

Core Viewpoint - Apple is planning to introduce AI-enhanced smart glasses to compete with Meta's Ray-Bans, with prototypes expected by the end of 2023 and a release targeted for late 2026 [1][2]. Group 1: Product Features - The smart glasses are anticipated to include cameras, microphones, speakers, and the Siri voice assistant, enabling functionalities such as phone calls, music playback, live translations, and turn-by-turn directions [2]. - Future iterations of the glasses are expected to incorporate augmented reality capabilities [2]. Group 2: Broader Strategy - The smart glasses initiative is part of Apple's larger strategy to develop a "breakthrough AI product" [2]. - Apple is also exploring the integration of cameras into its Apple Watch and AirPods to enhance data collection, although work on the smartwatch has been halted [3]. Group 3: Industry Context - A new wave of next-generation smart glasses driven by AI is emerging, with companies like Meta, Amazon, Snap, Samsung, Baidu, Xiaomi, and Google investing in this market [4]. - Google is developing smart glasses with its Android XR operating system and AI model, Gemini, aiming to create a convenient AI assistant [4][5].

Group 1 - STAG Industrial (NYSE: STAG) is an industrial REIT that offers monthly dividends, making it attractive to individual investors [1] - The author has previously expressed a bullish thesis on STAG Industrial and holds a personal investment in the company [1] - The focus of the author's investment strategy is on dividend investing, which is viewed as a straightforward path to financial freedom [2] Group 2 - The author has extensive experience in M&A and business valuation, having evaluated numerous businesses and participated in key transactions [2] - The sectors of focus for the author's investment and advisory work include technology, real estate, software, finance, and consumer staples [2] - The motivation for sharing insights on dividend investing is to help others navigate the process and build long-term wealth [2]

Core Viewpoint - Silvercorp reported quarterly earnings of $0.07 per share, missing the Zacks Consensus Estimate of $0.09 per share, but showing an improvement from $0.02 per share a year ago, indicating a -22.22% earnings surprise [1] Financial Performance - The company posted revenues of $75.11 million for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 0.02%, and showing significant growth from year-ago revenues of $42.68 million [2] - Over the last four quarters, Silvercorp has surpassed consensus EPS estimates two times and topped consensus revenue estimates four times [2] Stock Performance - Silvercorp shares have increased approximately 30.3% since the beginning of the year, contrasting with the S&P 500's decline of -0.6% [3] Future Outlook - The company's earnings outlook is crucial for investors, with current consensus EPS estimates at $0.10 for the coming quarter and $0.30 for the current fiscal year, alongside expected revenues of $85 million and $287.7 million respectively [7] - The estimate revisions trend for Silvercorp is currently mixed, resulting in a Zacks Rank 3 (Hold), suggesting the shares are expected to perform in line with the market in the near future [6] Industry Context - The Mining - Miscellaneous industry, to which Silvercorp belongs, is currently ranked in the bottom 41% of over 250 Zacks industries, indicating that the industry's outlook can significantly impact the stock's performance [8]

Core Insights - United Airlines has experienced significant growth over the past year, marked by record earnings and a notable increase in international traffic [1] - The company has successfully shifted towards a more premium product offering, enhancing its market position [1] - Despite these successes, there are concerns regarding the potential impact of economic turbulence on future performance [1] Financial Performance - The airline has reported record earnings, indicating strong financial health and operational efficiency [1] - The surge in international traffic suggests a recovery in global travel demand, which is crucial for the airline's revenue growth [1] Strategic Initiatives - United Airlines has pivoted towards offering more premium products, which may attract higher-paying customers and improve profit margins [1] - This strategic shift aligns with broader industry trends focusing on enhancing customer experience and service quality [1]

Core Viewpoint - Fulgent Genetics, Inc. is under investigation for potential violations of federal securities laws and unlawful business practices, following a civil investigative demand from the U.S. Department of Justice regarding false claims submitted under the Uninsured Program [1][2]. Group 1: Company Investigation - Bragar Eagel & Squire, P.C. is investigating potential claims against Fulgent on behalf of its stockholders [1]. - The investigation is focused on whether Fulgent has engaged in unlawful business practices or violated federal securities laws [1]. - Following the disclosure of the civil investigative demand, Fulgent's stock price decreased by $0.41 per share, or 2.61%, closing at $15.28 per share [2]. Group 2: Legal Context - The civil investigative demand was received by Fulgent from the U.S. Department of Justice, indicating serious scrutiny regarding the company's claims under the Uninsured Program [2]. - The law firm Bragar Eagel & Squire, P.C. specializes in representing investors in complex litigation, which includes securities and derivative cases [4].

Core Viewpoint - Bragar Eagel & Squire, P.C. is investigating potential claims against Apple Inc. regarding possible violations of federal securities laws and unlawful business practices [1] Group 1: Company Developments - On March 7, 2025, Apple announced a significant delay in the availability of Apple Intelligence, stating that more time was needed to develop new Siri features to enhance its AI capabilities [2] - Following the announcement of the delay, Apple’s stock price fell over 5% on March 10, 2025 [2] Group 2: Legal Investigation - The investigation by Bragar Eagel & Squire, P.C. is focused on whether Apple has engaged in unlawful business practices that may have affected stockholders [1] - Stockholders who have suffered losses and are interested in the investigation can contact the law firm for more information [3]

Core Viewpoint - ADTRAN Holdings, Inc. is under investigation for potential violations of federal securities laws and unlawful business practices, following the disclosure of issues with its financial statements [1][2]. Financial Disclosure - On May 13, 2025, ADTRAN announced that its audited consolidated financial statements for the years ended December 31, 2024, and December 31, 2023, as well as its unaudited condensed financial statements for interim periods in 2024, should no longer be relied upon and would be restated [2]. - The company identified at least one additional material weakness in its internal control over financial reporting as of December 31, 2024 [2]. - Following this announcement, ADTRAN's stock price decreased by $0.41, or 4.79%, closing at $8.15 per share on May 14, 2025 [2]. Legal Investigation - Bragar Eagel & Squire, P.C. is investigating potential claims on behalf of ADTRAN stockholders who may have suffered losses due to the company's financial disclosures [1][3].

Core Viewpoint - Semler Scientific Inc. is under investigation for potential violations of federal securities laws and unlawful business practices, particularly concerning its QuantaFlo device reimbursement claims [1][2]. Company Summary - Semler filed its Form 10-K with the SEC on February 28, 2025, revealing an initial civil investigative demand from the U.S. Department of Justice (DOJ) dating back to July 2017 [2]. - The company has faced multiple requests for information from the DOJ, with significant dates including February 2019, December 2021, April 2022, and April 2023 [2]. - Settlement discussions with the DOJ in February 2025 were unsuccessful, leading to concerns that the DOJ may file a civil False Claims Act lawsuit against Semler [2]. - Following the news of the investigation, Semler's share price dropped from $42.92 to $38.89, a decline of $4.03 per share, between February 28 and March 3, 2025 [2]. Legal Context - Bragar Eagel & Squire, P.C. is investigating potential claims on behalf of Semler stockholders regarding the company's legal issues [1]. - The law firm specializes in representing investors in complex litigation, including securities and derivative cases [4].

Core Viewpoint - Bragar Eagel & Squire, P.C. is investigating potential claims against Intellia Therapeutics, Inc. regarding breaches of fiduciary duties by the board of directors following a class action complaint related to the company's Phase 1/2 study and subsequent reorganization [1][2][3] Group 1: Legal Investigation - A class action complaint was filed against Intellia on February 11, 2025, with a class period from July 30, 2024, to January 8, 2025 [1] - The investigation focuses on whether Intellia's board of directors failed to disclose critical information regarding the demand for viral-based editing and the inefficiency of the NTLA-3001 program [2] Group 2: Company Reorganization - On January 9, 2025, Intellia announced a reorganization, halting all NTLA-3001 research and reducing its workforce by 27% in 2025 [3] - The decision to discontinue NTLA-3001 was part of a broader strategy to focus resources on other pharmaceutical developments [3] Group 3: Stock Price Impact - Following the announcement of the reorganization, Intellia's stock price dropped from $12.02 per share on January 8, 2025, to $10.20 per share on January 10, 2025 [4]